TCON TRACON Pharmaceuticals Operating Margin

TCON (TRACON Pharmaceuticals Inc.) - company brandmark

A total collapse following failed tests led to the liquidation of TRACON Pharmaceuticals (TCON) assets. The operating income ratio on GURU.Markets visualizes this decline, where the value 0.00 shows the current magnitude. Previously, the business relied on the development of oncology drugs and antibodies for tumor therapy. Capitalization was based on royalties and upfront payments from partners treating rare forms of cancer.

TCON: TRACON Pharmaceuticals Inc. Operating Return on Sales 07/04/2022 - 08/04/2024

Financial and market metric breakdowns for TRACON Pharmaceuticals (TCON)

- share price and consensus valuation forecast:
Initial company analysis:TRACON Pharmaceuticals, Inc, TCON
Brand item of TRACON Pharmaceuticals, Inc

For the biopharmaceutical sector of TRACON Pharmaceuticals (TCON), which is characterized by a lack of stable sales and a dependence on external capital, the operating margin serves as a critical indicator of cost control. When analyzing the level of operational efficiency, an investor assesses the ratio of operating profit to revenue, where sharp fluctuations in the curve often signal temporary spikes in efficiency followed by a reversion to the mean.

Analysis of competing companies

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|NAUT - Operating Margin|MGX: Operating Margin|Operating Sales Margin Precision BioSciences, Inc.|GBIO (Generation Bio) - Operating Margin|Boundless Bio Inc. (BOLD) - Profitability of Operations|Operating Sales Margin XCUR (exicuretx.com)|Imunon Inc - Return on Sales by Operating Profit|Operating Margin PHIO (Phio Pharmaceuticals Corp)|Operating Profit Rate MBIO|RNAZ - Operating Profitability|Operating Profit Rate BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operating Profitability|Bluebird Bio - Operating Profit Rate|IPA (ImmunoPrecise Antibodies Ltd) - Operating Margin|Operating Return on Sales Omega Therapeutics, Inc. OMGA|Operating Margin OMIC|RGLS (Regulus Therapeutics Inc.) - Operating Profit Rate|Operating Margin SYRS (Syros Pharmaceuticals Inc.)|Operating Profit Ratio TBIO (Codex DNA)|UBX - Operating Profitability